scientific article; zbMATH DE number 1984442
From MaRDI portal
Publication:4428801
Recommendations
- Adaptive Bayesian compound designs for dose finding studies
- Bayesian adaptive designs for clinical trials
- A Bayesian adaptive design in clinical trials for continuous responses
- scientific article; zbMATH DE number 5898591
- A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate
- Bayesian design for clinical trials with a constraint on the total available dose
- Bayesian adaptive methods for clinical trials
- Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information
Cited in
(27)- Seamlessly expanding a randomized phase II trial to phase III
- scientific article; zbMATH DE number 5898591 (Why is no real title available?)
- Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design
- Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers
- Dynamic Programming for Response-Adaptive Dose-Finding Clinical Trials
- Incorporating Bayesian ideas into health-care evaluation
- A combined proof of concept and dose finding study with multiple endpoints: A Bayesian adaptive design in chronic prostatitis/chronic pelvic pain syndrome
- Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information
- Bayesian design for clinical trials with a constraint on the total available dose
- Dose-finding designs for HIV studies
- Bayesian decision procedures based on logistic regression models for dose-finding studies
- Min-Max Optimal Design of Two-Armed Trials with Side Information
- Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
- Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates
- Flexible link continual reassessment methods for trivariate binary outcome phase I/II trials
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
- Sequential methods in multi-arm clinical trials
- Simulation-based sequential Bayesian design
- Celebrating 70: an interview with Don Berry
- Approximating the operating characteristics of Bayesian uncertainty directed trial designs
- Bayesian learning of dose-response parameters from a cohort under response-guided dosing
- Optimal stopping for response-guided dosing
- Bayesian statistics and the efficiency and ethics of clinical trials
- Population modelling of patient responses in antidepressant studies: a stochastic approach
- Optimizing the concentration and bolus of a drug delivered by continuous infusion
- Adaptive Bayesian compound designs for dose finding studies
- A review of phase 2-3 clinical trial designs
This page was built for publication:
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4428801)
